Mito-FLAG regimen

WikiDoc Resources for Mito-FLAG regimen
Articles
Most recent articles on Mito-FLAG regimen Most cited articles on Mito-FLAG regimen Review articles on Mito-FLAG regimen Articles on Mito-FLAG regimen in N Eng J Med, Lancet, BMJ
Media
Powerpoint slides on Mito-FLAG regimen Images of Mito-FLAG regimen Photos of Mito-FLAG regimen Podcasts & MP3s on Mito-FLAG regimen Videos on Mito-FLAG regimen
Evidence Based Medicine
Cochrane Collaboration on Mito-FLAG regimen Bandolier on Mito-FLAG regimen TRIP on Mito-FLAG regimen
Clinical Trials
Ongoing Trials on Mito-FLAG regimen at Clinical Trials.gov Trial results on Mito-FLAG regimen Clinical Trials on Mito-FLAG regimen at Google
Guidelines / Policies / Govt
US National Guidelines Clearinghouse on Mito-FLAG regimen NICE Guidance on Mito-FLAG regimen NHS PRODIGY Guidance FDA on Mito-FLAG regimen CDC on Mito-FLAG regimen
Books
Books on Mito-FLAG regimen
News
Mito-FLAG regimen in the news Be alerted to news on Mito-FLAG regimen News trends on Mito-FLAG regimen
Commentary
Blogs on Mito-FLAG regimen
Definitions
Definitions of Mito-FLAG regimen
Patient Resources / Community
Patient resources on Mito-FLAG regimen Discussion groups on Mito-FLAG regimen Patient Handouts on Mito-FLAG regimen Directions to Hospitals Treating Mito-FLAG regimen Risk calculators and risk factors for Mito-FLAG regimen
Healthcare Provider Resources
Symptoms of Mito-FLAG regimen Causes & Risk Factors for Mito-FLAG regimen Diagnostic studies for Mito-FLAG regimen Treatment of Mito-FLAG regimen
Continuing Medical Education (CME)
CME Programs on Mito-FLAG regimen
International
Mito-FLAG regimen en Espanol Mito-FLAG regimen en Francais
Business
Mito-FLAG regimen in the Marketplace Patents on Mito-FLAG regimen
Experimental / Informatics
List of terms related to Mito-FLAG regimen

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Aparna Vuppala, M.B.B.S. [2]

Overview

Mito-FLAG regimen refers to a regimen consisting of mitoxantrone, fludarabine, cytarabine as bolus (B) or continuous infusion (CI) and granulocyte- colony stimulating factor (G-CSF) in patients with recurrent and refractory acute myeloid leukemia (AML).

Regimen

MitoMitoxantrone

FLFludarabine

ACytarabine (AraC)

GGranulocyte- colony stimulating factor

Indications

• Recurrent and Refractory acute myeloid leukemia (AML)